Shares of Relx Plc (NYSE:RELX – Get Free Report) have been given a consensus recommendation of “Buy” by the five analysts that are covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company.
A number of research firms have recently issued reports on RELX. StockNews.com cut Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Barclays upgraded Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. The Goldman Sachs Group began coverage on Relx in a research report on Wednesday, March 26th. They set a “buy” rating on the stock. Finally, Morgan Stanley restated an “overweight” rating on shares of Relx in a research report on Wednesday, April 16th.
Read Our Latest Analysis on Relx
Institutional Trading of Relx
Relx Stock Up 1.2%
Shares of RELX stock opened at $53.02 on Monday. Relx has a 12 month low of $43.28 and a 12 month high of $55.21. The firm has a market cap of $98.13 billion, a PE ratio of 28.51, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86. The stock has a 50 day moving average of $50.86 and a 200-day moving average of $48.80. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46.
Relx Increases Dividend
The business also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be given a $0.5586 dividend. This represents a yield of 1.6%. This is a boost from Relx’s previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. Relx’s dividend payout ratio is 59.68%.
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Further Reading
- Five stocks we like better than Relx
- Dividend Payout Ratio Calculator
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- How to Use the MarketBeat Stock Screener
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
- Stock Sentiment Analysis: How it Works
- 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.